Professor Michael Lisanti
Chair of translational medicine at Salford University, Manchester.
Chair of The Healthy Life Foundation Scientific Advisory Board.
An active research scientist for more than three decades with a broad background in cell biology and genetics, Professor Lisanti graduated with a degree in Chemistry (Magna Cum Laude) from New York University and obtained his MD-PhD at Cornell University Medical School in Cell Biology and Genetics. From 1992-96, he was a Skeggs Fellow at the Whitehead Institute for Biomedical Research at the Massachusetts Institute of Technology (MIT), followed by several distinguished appointments at the Albert Einstein College of Medicine and the Kimmel Cancer Centre. Professor Lisanti joined Manchester University in 2012 as Professor of Cancer Biology. He is currently listed amongst the Top 100 Most-Cited Researchers in Biochemistry and Biology. He has an H-index >120, with over 50,000 citations. Moreover, he has published > 480 papers and is the former Editor-in-Chief of The American Journal of Pathology.
Dr Federica Sotgia – Senior Lecturer Manchester University
Federica obtained her PhD in Medical Genetics in 2001 from the University of Genova, Italy. She then moved to Albert Einstein College of Medicine, New York, as a post-doctoral fellow, where she was promoted to Instructor. In 2006, she was appointed as an Assistant Professor in the Department of Cancer Biology at the Kimmel Cancer Center, Thomas Jefferson University, in Philadelphia. In September 2012, she started her new role at the University of Manchester as a Senior Lecturer. She has a background in skeletal muscle biology and mitochondrial oxidative phosphorylation.
As a PhD student, she was the first to discover that mutations in the caveolin-3 gene are the cause of a novel form of limb-girdle muscular dystrophy, named LGMD-1C. Later on in my career, she developed an interest in breast cancer, and she has applied the knowledge and expertise gained from studying mitochondrial metabolism to the breast cancer field.
Dr Clare Elizabeth Conlon MBChB, FRCA
The health and well being of my patients is of utmost importance. I graduated as a doctor from the University of Edinburgh Medical School in 2003 and began my training in anaesthetics becoming a Fellow of the Royal College of Anaesthetists in 2008.
• Bachelor of Medicine and Surgery awarded from University of Edinburgh Medical School.
• Fellow of the Royal College of Anaesthetists
Why I sit on the OMGTEA Advisory Board
Like all of us I want to protect my health and health of my family and there was nothing more important than this when my mother was diagnosed with Breast Cancer in 2008.
I have often wondered when we as a society are going to become more powerful in battling against the very high occurrence of cancer. This year we have hit 10,000 new breast cancer diagnosis in the under 50s in the UK for the first time.
Through working as an anaesthetist I have become aware of and involved in research into the treatment and prevention on cancer and it is through this that I have become familiar with the general health benefits of supplementing with antioxidants. OMGTea has an astonishing level of antioxidants
I am so convinced by the research in this area that I religiously drink OMGTea every single day for my own personal battle against cancer, having been identified as higher risk, and from the experience of my mother’s battle with the disease. I am overjoyed to say that my mother is fit and well and taking OMGTea on a daily basis too. Many of my family and friends are also now convinced of the health benefits of OMGTea products. Its comforting to know that getting Matcha into our diet is one small thing we can do every day to give us the reassurance that we will maintain good health for as long as possible.